Adagrasib Shows “Durable Clinical Benefit” in Advanced KRAS-Mutant NSCLC
Adagrasib has shown durable clinical activity in patients with advanced KRASG12C-mutant NSCLC, according to updated results from the KRYSTAL-1 trial.
Dabrafenib, Trametinib Active in Pediatric Glioma With BRAF V600
More responses, longer progression-free survival seen compared with standard chemo for low-grade glioma with BRAF V600 mutations.
Vitamins C, D Supplementation Beneficial in Chemotherapy for Acute Myeloid Leukemia
Use of vitamin C and D supplementation evaluated for its efficacy for patients with AML undergoing intensive induction chemotherapy.
Air Pollution Linked to Increased Risk of Breast Cancer
Long-term historical exposure to air pollution is associated with an increased risk of breast cancer, a new study suggests.
First-Line Benmelstobart Regimen Produces Longest PFS, OS to Date in ES-SCLC
Adding benmelstobart and anlotinib to first-line chemotherapy improved survival outcomes in a phase 3 trial of patients with ES-SCLC.
Advanced Young-Onset Adenoma Increases Colorectal Cancer Risk
However, overall 10-year colorectal cancer incidence relatively low in veterans younger than 50 years of age.
Adding Serplulimab to Chemotherapy Improves Survival in Squamous NSCLC
First-line treatment with serplulimab plus chemotherapy improves survival over chemotherapy alone in patients with advanced squamous NSCLC, a phase 3 trial suggests.
Regular Opioid Use May Increase the Risk of Lung Cancer
Researchers found that patients who used opioids regularly had a roughly 30% higher risk of lung cancer than patients who did not use opioids.
Adults Overdue for CRC Screen Rarely Receive Recommendation for Screening
Prevalence of reporting clinician recommendation was lower for non-Hispanic Asian, Black, Hispanic versus White adults.
Nutritional Status, Symptom Severity Affect Quality of Life in Operable Pancreatic Cancer
Researchers evaluated the differences in malnutrition status, severity of symptoms, and anorexia-cachexia-related QOL prior to and 3 months following pancreatic cancer surgery.
- Loading...
